FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

704226002: Pertuzumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3012148012 Pertuzumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3012447013 Pertuzumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pertuzumab Is a Monoclonal antibody agent false Inferred relationship Some
Pertuzumab Is a Monoclonal antibody true Inferred relationship Some
Pertuzumab Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Pertuzumab Has disposition (attribute) Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Some
Pertuzumab Is a Antineoplastic agent (substance) false Inferred relationship Some
Pertuzumab Is a Enzyme inhibitor protein true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Pertuzumab 30mg/mL solution for injection Has active ingredient False Pertuzumab Inferred relationship Some
Product containing pertuzumab (medicinal product) Has active ingredient True Pertuzumab Inferred relationship Some 1
Pertuzumab only product Has active ingredient True Pertuzumab Inferred relationship Some 1
Pertuzumab-containing product in parenteral dose form Has active ingredient True Pertuzumab Inferred relationship Some 1
Product containing only pertuzumab in parenteral dose form (medicinal product form) Has active ingredient True Pertuzumab Inferred relationship Some 1
Product containing precisely pertuzumab 80 milligram/1 milliliter and trastuzumab 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Pertuzumab Inferred relationship Some 2
Product containing precisely pertuzumab 80 milligram/1 milliliter and trastuzumab 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pertuzumab Inferred relationship Some 2
Product containing precisely pertuzumab 60 milligram/1 milliliter and trastuzumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Pertuzumab Inferred relationship Some 2
Product containing precisely pertuzumab 60 milligram/1 milliliter and trastuzumab 60 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Pertuzumab Inferred relationship Some 2
Pertuzumab and trastuzumab only product in parenteral dose form Has active ingredient True Pertuzumab Inferred relationship Some 2
Product containing pertuzumab and trastuzumab in parenteral dose form (medicinal product form) Has active ingredient True Pertuzumab Inferred relationship Some 2
Pertuzumab and trastuzumab only product Has active ingredient True Pertuzumab Inferred relationship Some 2
Product containing pertuzumab and trastuzumab (medicinal product) Has active ingredient True Pertuzumab Inferred relationship Some 2

This concept is not in any reference sets

Back to Start